Anti-Thrombotic Medication Significantly Reduces Risk of Death for Heart Attack Patients
Heart Attack Treatment
Heart attack patients who have a certain pattern on an electrocardiogram significantly reduced their risk of death and having another heart attack at 30 days with the medication fondaparinux, without an increased risk of bleeding and strokes, according to a study that will appear in the April 5 issue of JAMA. The study is being released early online to coincide with its presentation at the American College of Cardiology annual conference.
Of 55 million deaths globally every year, about 30 percent are from cardiovascular diseases. Of these, 40 percent to 50 percent are likely to be due to acute myocardial infarction (AMI